Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial

Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial

Abstract Objectives The main objective of this study is to evaluate the effect of intravenous lidocaine on gas exchange and inflammation in acute respiratory distress syndrome due or not to Covid-19 pneumonia. Trial design This is a prospective monocentric, randomized, quadruple-blinded and placebo-...

Full description

Bibliographic Details
Main Authors: Marie Muller, François Lefebvre, Marie-Line Harlay, Ludovic Glady, Guillaume Becker, Charlotte Muller, Ouafaa Aberkane, Mira Tawk, Madoé Julians, Arnaud Romoli, Stéphane Hecketsweiler, Francis Schneider, Julien Pottecher, Thiên-Nga Chamaraux-Tran
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Trials
Subjects:
COVID-19
Randomised controlled trial
protocol
lidocaine
local anaesthetics
severe acute respiratory syndrome
Online Access:https://doi.org/10.1186/s13063-021-05095-x

Internet

https://doi.org/10.1186/s13063-021-05095-x

Similar Items